Philips Appoints Medical Device Expert to Supervisory Board
Royal Philips has announced the proposed appointment of John DeFord as a new member of the supervisory board, along with the reappointment of three outgoing directors. These changes will be submitted to the general shareholders' meeting scheduled for May 8, 2026.
John DeFord, an American citizen born in 1962, is proposed for appointment as a new member of Philips' supervisory board. His nomination is based on his extensive experience in the medical device industry as a global technology leader and his deep expertise in regulatory affairs and quality systems, particularly in the United States. Mr. DeFord currently serves as the president and CEO of Samothrace Medical Innovations since 2021. Prior to 2021, he was the Chief Technology Officer at Becton Dickinson, having previously held senior leadership positions at C.R. Bard. He also holds non-executive director positions at Nordson Corporation, Globus Medical, Inc., Maravai LifeSciences Holdings, Inc., and Enable Injections Inc.
Reappointment of Existing Board Members
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The supervisory board also proposes the reappointment of Paul Stoffels (Belgian, born 1962), Herna Verhagen (Dutch, born 1966), and Sanjay Poonen (American, born 1969) as members of the supervisory board. Marc Harrison (American, born 1964), whose second term expires at the end of the 2026 general meeting, will leave the supervisory board. Mr. Harrison joined the board in 2018 and served two consecutive terms. Additionally, Roy Jakobs (Dutch/German, born 1974) is proposed to be reappointed as chairman and CEO, and chairman of the board of directors and member of the management board, as previously announced on February 10, 2026.
SectorSanté · Technologie · Dispositifs médicaux›Équipements Médicaux
Context
Period
Period: 1T2026
Key reported figures
Revenue: 3.9MD€
Free cash flow: 28M€
Guidance from the release
Nous avons délivré un bon départ en 2026.
Bonne performance au T1, croissance des ventes et des marges.
Risks mentioned
Impact des tarifs et inflation des coûts sur les marges.
Environnement macroéconomique incertain impactant les performances.
Opportunities identified
Croissance des ventes comparables de 4% dans tous les segments.
Augmentation du carnet de commandes grâce à des innovations.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
